Workflow
Qiagen (NYSE:QGEN) 2025 Conference Transcript
快而精医药快而精医药(US:QGEN)2025-09-25 18:47

Qiagen (NYSE:QGEN) 2025 Conference September 25, 2025 05:45 AM ET Company ParticipantsJohn Gilardi - Head of IRMichael Ryskin - Managing Director of Life Science Tools & DiagnosticsOlivier Loeillot - CEOJason Garland - CFOMichael RyskinThanks for joining us. My name is Mike Riskin. I'm on the Bank of America Life Science Tools and Diagnostics team, based out of New York. We're excited for our next session. We're joined by John Gilardi, Head of Investor Relations for QIAGEN. John, thank you so much for being ...